HLA-B8,DR3 PHENOTYPE AND THE ANTIBODY-RESPONSE AGAINST EPSTEIN-BARR-VIRUS

被引:6
作者
CARUSO, C [1 ]
CANDORE, G [1 ]
COLUCCI, AT [1 ]
CIGNA, D [1 ]
SAMMARTANO, F [1 ]
AMMATUNA, P [1 ]
机构
[1] UNIV PALERMO,DIPARTIMENTO IGIENE & MICROBIOL,I-90134 PALERMO,ITALY
关键词
D O I
10.3109/08820139309066192
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies against the viral capsid antigen (VCA) and nuclear antigens (EBNAs) of the Epstein-Barr virus (EBV) were determined in a sample of Sicilian population. A significant correlation was observed between HLA-BB,DR3 phenotype and reduced titres of antibodies to EBNAs, whereas HLA-BB,DR3 positive individuals displayed levels of antibodies to VCA comparable to those of HLA-BB,DR3 negative ones. These results further strenghten the suggestion that HLA-BB,DR3 positive subjects are low responders and that the depth of immune response depends on on the fashion of antigenic challenge.
引用
收藏
页码:41 / 51
页数:11
相关论文
共 32 条
[1]   SPECIAL CHARACTERISTICS OF CELLULAR IMMUNE FUNCTION IN NORMAL INDIVIDUALS OF THE HLA-DR3-TYPE [J].
AMBINDER, JM ;
CHIORAZZI, N ;
GIBOFSKY, A ;
FOTINO, M ;
KUNKEL, HG .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 23 (02) :269-274
[2]  
AMER A, 1986, TISSUE ANTIGENS, V28, P193
[3]   IMMUNE STATUS TOWARDS EPSTEIN-BARR VIRUS IN A GROUP OF SICILIAN CHILDREN [J].
AMMATUNA, P ;
DISTEFANO, R ;
ARISTA, S ;
SAMMARTANO, F ;
BELLIA, L ;
FORMICA, P ;
ALBEGGIANI, A .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1989, 5 (02) :219-223
[4]  
CANDORE G, 1989, Medical Science Research, V17, P735
[5]   HLA-B8,DR3 T-CELL IMPAIRMENT IS COMPLETELY RESTORED BY INVITRO TREATMENT WITH INTERLEUKIN-2 [J].
CANDORE, G ;
COLUCCI, AT ;
MODICA, MA ;
CARUSO, C .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1991, 13 (04) :551-561
[6]  
CARUSO C, 1990, NEW ENGL J MED, V322, P550
[7]   HLA-DR3 AND IMMUNORESPONSIVENESS [J].
CARUSO, C ;
CANDORE, G ;
MODICA, MA .
LANCET, 1990, 336 (8713) :506-507
[8]  
CARUSO C, 1983, TISSUE ANTIGENS, V22, P167
[9]  
COHEN JHM, 1984, TISSUE ANTIGENS, V23, P156
[10]  
DAUSSET J, 1980, PROGR IMMUNOLOGY, V4, P513